Researchers in the lab of Dr. Christopher Pack at the Neuro found, in a new study, that as visual stimuli size increases, so too does the neural “noise” produced. Understanding the noise suppression process could help researchers find ways to compensate for brain impairments and improve vision.
On June 14, Dr. David Eidelman, Vice Principal (Health Affairs) and Dean of Medicine, hosted a reception in Holmes Hall to honour outgoing Faculty leaders for their outstanding contributions to the Faculty of Medicine and to McGill University.
In June, The Neuro, a major centre for ALS research and patient care, redoubles its efforts to inform the public and the media about amyotrophic lateral sclerosis (ALS). Dr. Angela Genge is director of The Neuro’s ALS Clinical Research Program, which handles about 300 patients annually.
Led by McGill’s Dr. Alan Evans, the Canadian research team that helped spearhead the international brain-mapping project known as BigBrain is about to get a major boost in its effort to produce sharply higher-resolution brain maps, thanks to technology from EMC Corporation.
McGill Medical students visit Harvard Medical School
Last March, a group of 6 students from Harvard Medical School visited McGill and Montreal as part of the first McGill-Harvard exchange. In late April, a group of McGill students made their way to Boston and to Harvard to complete the exchange. Medical student Mary Koziol recounts the story of the McGill students’ trip.
In a new video, Dr. Isabelle Gagnon, Associate Professor at the McGill School of Physical and Occupational Therapy shares advice with parents for dealing with concussions, an important issue as the weather warms and more children head outdoors to play.
Goodman Gala raises crucial funding for cancer research
McGill’s 4th Goodman Cancer Research Gala held in Montreal on June 5 raised more than $2.1 million in support of the critical research taking place at the Rosalind and Morris Goodman Cancer Research Centre.
You’re ill. You visit a doctor who examines you, diagnoses you with a once deadly cancer, immediately offers some non-invasive treatment, and sends you home with a good prognosis, relatively free of pain and side effects. It’s a scene straight out of Star Trek, but it might not be too far from reality.
The MDCM curriculum entitled, Patient at Heart, Science in Hand was implemented in the fall of 2013. It is a product of five years of reflection, multi-disciplinary consultation, planning and development.